On‐line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes
- 6 January 2006
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 23 (1) , 90-93
Abstract
Aims To evaluate an algorithm with glucose prediction capacity and continuous adaptation of patient parameters—a model predictive control (MPC) algorithm—to control blood glucose concentration during fasting conditions in patients with Type 1 diabetes. In the subcutaneous (sc) route within a closed loop system.Methods Paired experiments were performed in six patients. Over 8 h the MPC algorithm was used to control glucose with s.c. insulin administration and two different glucose monitoring protocols: first, the algorithm was provided with intravenous (i.v.) glucose values for insulin dosage calculation directly (i.v.–s.c. route). Then, in the second experiment, i.v. glucose values were fed to the MPC with a delay of 30 min to simulate s.c. glucose measurements (‘s.c.’–s.c. route). In both experiments plasma glucose, insulin dosage, and serum insulin levels were analysed.Results Glucose concentration was brought from hyper‐ to normoglycaemia and kept in the physiological range (6–7 mmol/l) with both routes in all subjects. Mean glucose concentration reached the threshold of 7 mmol/l approximately 2 (i.v.–s.c. route) and 3 (‘s.c.’–s.c. route) hours after the start of glucose control with the MPC. During the last 2 h of automated glucose control, mean glucose concentration was 6.3 ± 0.2 mmol/l and 6.6 ± 0.3 mmol/l for i.v.–s.c. and ‘s.c.’–s.c. route, respectively. Glucose concentration, insulin doses, and serum insulin levels did not differ significantly between routes (P > 0.05).Conclusions The MPC algorithm is suitable for glucose control during fasting within an extracorporeal artificial β‐cell in the subcutaneous route Type 1 diabetic patients.Keywords
This publication has 14 references indexed in Scilit:
- Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetesPhysiological Measurement, 2004
- Closing the Loop: The Adicol ExperienceDiabetes Technology & Therapeutics, 2004
- Diabetes management in the new millennium using insulin pump therapyDiabetes/Metabolism Research and Reviews, 2002
- Recent advances in continuous glucose monitoringExperimental and Clinical Endocrinology & Diabetes, 2001
- Subcutaneous Continuous Glucose MonitoringDiabetes Care, 2001
- The intravenous route to blood glucose controlIEEE Engineering in Medicine and Biology Magazine, 2001
- Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoringAmerican Journal of Physiology-Endocrinology and Metabolism, 1999
- 24-hour glucose profiles during continuous or oscillatory insulin infusion. Demonstration of the functional significance of ultradian insulin oscillations.Journal of Clinical Investigation, 1995
- [Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human InsulinDiabetes, 1994
- Clinical Control of Diabetes by the Artificial PancreasDiabetes, 1974